Back to mobile site

Bank of America cuts Pfizer (PFE) on post-Covid uncertainties, upgrades Merck (MRK)

January 4, 2023 9:10 AM EST Send to a Friend
Bank of America analyst Geoff Meacham downgraded Pfizer (NYSE: PFE) stock to Neutral from Buy, citing long-term uncertainty. The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login